Xilinx, Inc. (NASDAQ: XLNX), Accenture Plc (NYSE: ACN), The Fresh Market Inc (NYSE: TFM), Accretive Health, Inc. (NYSE: AH), Oneok Partners LP (NYSE: OKS) and AMETEK, Inc. (NYSE: AME) had their ratings on them reiterated by analysts.
JPMorgan Chase & Co. (NYSE:JPM) reiterated its “Overweight” rating on Xilinx, Inc. (XLNX).
Morgan Stanley (NYSE:MS) reiterated its “Overweight” rating on Accenture Plc (ACN).
JPMorgan Chase & Co. reiterated its “Overweight” rating on The Fresh Market Inc. (TFM).
JPMorgan Chase & Co. reiterated its “Overweight” rating on Accretive Health, Inc. (AH). They have a price target of $35.00 on the company.
Oppenheimer Oneok reiterated its “Outperform” rating on Partners LP (OKS).
Oppenheimer reiterated its “Outperform” rating on AMETEK, Inc. (AME).
Friday, September 23, 2011
Xilinx (XLNX) (ACN) (TFM) (AH) (OKS) (AME) Ratings Reiterated
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment